Showing results (581-590 of 588) with videos related to
Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 588 results.
Journal of Medicinal Chemistry|February 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin LymphomaDeborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas, et al.Journal of Medicinal Chemistry|November 24, 2025
Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed DegradersBryan J Simmons, Lynda Groocock, Jesus Moreno, et al.Journal of Medicinal Chemistry|June 24, 2015
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.Journal of Medicinal Chemistry|June 18, 2015
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.Medical Image Analysis|June 18, 2023
Towards clinical applicability and computational efficiency in automatic cranial implant design: An overview of the AutoImplant 2021 cranial implant design challengeJianning Li, David G Ellis, Oldřich Kodym, et al.Journal of Medicinal Chemistry|July 10, 2026
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365Deborah S Mortensen, Surendra Nayak, Veronique Plantevin-Krenitsky, et al.JAMA Neurology|May 23, 2025
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021, Ilari Rautalin, Victor Volovici, et al.JAMA|July 29, 2026
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023, Christian Razo, Nicole K DeCleene, et al.Pageof 59